Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma (Pediatric)
Location: United States, FL
Does your child have asthma?
A 6-month safety and benefit study of inhaled fluticasone
propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma. There is no placebo in this clinical research study. There will be no blood draws during this clinical research study. All study participants will receive asthma medication at no charge. Health insurance is not needed to participate. Compensation may be provided for time and travel. Patient Inclusion Description: Are 4 to 11 years of age, have had asthma for at least six months, have had asthma bad enough to see a doctor in the last 12 months.
Patient Exclusion Criteria:
CW ID: 182057
Date Last Changed:
July 18, 2013
Jeffrey Hirschfield, M.D., Principal InvestigatorSCORE Physician Alliance6499 38Th Avenue North, Suite A-2St. Petersburg, FL 33710Phone: 727-381-4305
Research Center Information: SCORE Physician Alliance
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.